“Marijuana (cannabis sativa) is a schedule 1 drug that has been recently approved by some states in the US for its therapeutic benefit.
Although there are a few reports about its anti-cancer potential, currently it has been used mainly for treatment-resistant epilepsy and to alleviate pain.
Hemp, which belongs to the same genus and species as marijuana, shows similar therapeutic benefits without addictive potential.
Our laboratory is interested in examining for unconventional therapies for ovarian cancer.
The main objective of the current study is to investigate hemp-induced modulation of A2780 ovarian cancer cell apoptosis.
Based on the data here we conclude that KY hemp has anti-cancer potential against ovarian cancer.”